Calcification of tissue heart valve substitutes: Progress toward understanding and prevention

Annals of Thoracic Surgery

Volumn 79, Issue 3, 2005, Pages 1072-1080

  Schoen, Frederick J ^a   Levy, Robert J ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA AMINO OLEIC ACID; ALUMINUM DERIVATIVE; AMINO ACID DERIVATIVE; ANTICOAGULANT AGENT; AZIDE; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHELATING AGENT; CALCIUM PHOSPHATE; CYANAMIDE; DETERGENT; DODECYL SULFATE SODIUM; EPOXIDE; ETHYLENE VINYL ACETATE COPOLYMER; ETIDRONIC ACID; FORMALDEHYDE; GLUTARALDEHYDE; IRON DERIVATIVE; PHOSPHORUS; POLYMER; POLYURETHAN; SILICONE; SURFACTANT; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALLOGRAFT; ANTICOAGULANT THERAPY; AORTA VALVE; BIOMECHANICS; BIOPROSTHESIS; BLEEDING; BLOOD FLOW; BONE MINERALIZATION; CALCIFICATION; CALCIUM METABOLISM; CHEMICAL MODIFICATION; CLINICAL TRIAL; COVALENT BOND; CROSS LINKING; DRUG DELIVERY SYSTEM; ELECTROLYTE DISTURBANCE; ENDOCARDITIS; EXTRACELLULAR FLUID; GROWTH RETARDATION; HEART VALVE PROSTHESIS; HEART VALVE STENOSIS; HUMAN; HYPERCALCEMIA; IMMUNE RESPONSE; INFLAMMATION; MECHANICAL STRESS; NONHUMAN; PATHOPHYSIOLOGY; PERICARDIUM; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW; SIDE EFFECT; THROMBOEMBOLISM; THROMBOSIS; VALVULAR HEART DISEASE;

EID: 14244266288     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2004.06.033     Document Type: Review

References (111)

1. W. Vongpatanasin, D. Hillis, R.A. Lange Prosthetic heart valves N Engl J Med 335 1996 407 416
2. F.J. Schoen, R.J. Levy Tissue heart valves current challenges and future research perspectives J Biomed Mater Res 47 1999 439 465
3. P. Bloomfield, D.J. Wheatley, R.J. Prescott, H.C. Miller Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses N Engl J Med 324 1991 573 579
4. K.E. Hammermeister, G.K. Sethi, W.G. Henderson, F.L. Grover, C. Oprian, S. Rahimtoola Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve Final Report of the Veterans Affairs Randomized Trial J Am Coll Cardiol 36 2000 1152 1158
5. F.J. Schoen, C.E. Hobson Anatomic analysis of removed prosthetic heart valves causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983 Hum Pathol 16 1985 549
6. J. Turina, O.M. Hess, M. Turina, H.P. Krayenbuehl Cardiac bioprostheses in the 1990s Circulation 88 1993 775 781
7. W.R. Jamieson, A.I. Munro, R.T. Miyagishima, P. Allen, L.H. Burr, G.F. Tyers Carpentier-Edwards standard porcine bioprosthesis clinical performance to seventeen years Ann Thorac Surg 60 1995 999 1006
8. L.H. Cohn, J.J. Collins, V.J. DiSesa Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements Ann Surg 210 1989 435 442
9. G.L. Grunkemeier, W.R. Jamieson, D.C. Miller, A. Starr Actuarial versus actual risk of porcine structural valve deterioration J Thorac Cardiovasc Surg 108 1994 709 718
10. I. Vesely, J.E. Barber, N.B. Ratliff Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure J Heart Valve Dis 10 2001 471
11. M.S. Sacks, F.J. Schoen Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves J Biomed Mater Res 62 2002 359 371
12. F.J. Schoen, J. Fernandez, L. Gonzalez-Lavin, A. Cernaianu Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses emphasis on progressive structural deterioration Circulation 76 1987 618 627
13. V.M. Walley, W.J. Keon Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves J Thorac Cardiovasc Surg 93 1987 925 933
14. G.R. Barnhart, M. Jones, T. Ishihara, D.M. Rose, A.M. Chavez, V.J. Ferrans Degradation and calcification of bioprosthetic cardiac valves bioprosthetic tricuspid valve implantation in sheep Am J Pathol 106 1982 136 139
15. F.J. Schoen, D. Hirsch, R.W. Bianco, R.J. Levy Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep J Thorac Cardiovasc Surg 108 1994 880 887
16. R.J. Levy, R.J. Schoen, J.T. Levy, A.C. Nelson, S.L. Howard, L.J. Oshry Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats Am J Pathol 113 1983 142 155
17. F.J. Schoen, R.J. Levy, A.C. Nelson Onset and progression of experimental bioprosthetic heart valve calcification Lab Invest 52 1985 523 532
18. F.J. Schoen, J.W. Tsao, R.J. Levy Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for mechanisms of bioprosthetic tissue mineralization Am J Pathol 23 1986 143 154
19. F.J. Schoen, G. Golomb, R.J. Levy Calcification of bioprosthetic heart valves a perspective on models J Heart Valve Dis 1 1992 110 114
20. G.M. Bernacca, G. Tobasnick, D.J. Wheatley Dynamic in-vitro calcification of porcine aortic valves J Heart Valve Dis 3 1994 684 687
21. W.J. Mako, I. Vesely In-vivo and in-vitro models of calcification in porcine aortic valve cusps J Heart Valve Dis 6 1997 316 323
22. E. Pettenazzo, M. Deiwick, G. Thiene Dynamic in vitro calcification of bioprosthetic porcine valves: evidence of apatite crystallization J Thorac Cardiovasc Surg 21 2001 500 509
23. G. Golomb, F.J. Schoen, M.S. Smith, J. Linden, M. Dixon, R.J. Levy The role of glutaraldehyde-induced crosslinks in calcification of bovine pericardium used in cardiac valve bioprostheses Am J Pathol 127 1987 122 130
24. M. Grabenwoger, J. Sider, F. Fitzal Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material Ann Thorac Surg 62 1996 772 777
25. P. Zilla, C. Weissenstein, P. Human, T. Dower, U.O. von Oppell High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model Ann Thorac Surg 70 2000 2091 2095
26. M.T. Bailey, S. Pillarisetti, H. Xiao, N.R. Vyavahare Role of elastin in pathologic calcification of xenograft heart valves J Biomed Mater Res 66 2003 93 102
27. R.J. Levy, F.J. Schoen, F.S. Sherman, J. Nichols, M.A. Hawley, S.A. Lund Calcification of subcutaneously implanted type I collagen sponges effects of glutaraldehyde and formaldehyde pretreatments Am J Pathol 122 1986 71 82
28. N. Vyavahare, M. Ogle, F.J. Schoen, R.J. Levy Elastin calcification and its prevention with aluminum chloride pretreatment Am J Pathol 155 1999 973 982
29. K. McGonagle-Wolff, F.J. Schoen Morphologic findings in explanted mitroflow pericardial bioprosthetic valves Am J Cardiol 70 1992 263 264
30. S.L. Hilbert, V.J. Ferrans, Y. Tomita, E.E. Eidbo, M. Jones Evaluation of explanted polyurethane trileaflet cardiac valve prostheses J Thorac Cardiovasc Surg 94 1987 419 429
31. F.J. Schoen, R.J. Levy, H.R. Piehler Pathological considerations in replacement cardiac valves Cardiovasc Pathol 1 1992 29 52
32. M.J. Thubrikar, J.D. Deck, J. Aouad, S.P. Nolan Role of mechanical stress in calcification of aortic bioprosthetic valves J Thorac Cardiovasc Surg 86 1983 115 125
33. M. Valente, U. Bortolotti, G. Thiene Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure Am J Pathol 119 1985 12
34. F.J. Schoen Future directions in tissue heart valves impact of recent insights from biology and pathology J Heart Valve Dis 8 1999 350 358
35. L.L. Demer Vascular calcification and osteoporosis inflammatory responses to oxidized lipids Intl J Epidemiol 31 2002 737 741
36. C.M. Giachelli Ectopic calcification gathering hard facts about soft tissue mineralization Am J Pathol 154 1999 671 675
37. Speer MY, Giachelli CM. Regulation of vascular calcification. Cardiovasc Pathol 2004;13:63-70.
38. R.J. Levy, C.M. Gundberg, R. Scheinman The identification of the vitamin K-dependent bone protein osteocalcin as one of the carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves Atherosclerosis 46 1983 49 56
39. T. Schinke, M.D. McKee, G. Karsenty Extracellular matrix calcification where is the action? Nature Genetics 21 1999 150 151
40. A. Bini, K.G. Mann, B.J. Kudryk, F.J. Schoen Non-collagenous bone proteins, calcification and thrombosis in coronary artery atherosclerosis Arterioscler Thromb Vasc Biol 19 1999 1852 1861
41. S.A. Steitz, M.Y. Speer, M.D. McKee Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification Am J Pathol 161 2002 2035 2046
42. F. Parhami, B. Basseri, J. Hwang, Y. Tintut, L.L. Demer High-density lipoprotein regulates calcification of vascular cells Circ Res 91 2002 570 576
43. S. Jono, M.D. McKee, C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 e10 e17
44. K. Bostrom, K.E. Watson, S. Horn, C. Wortham, I.M. Herman, L.L. Demer Bone morphogenetic protein expression in human atherosclerotic lesions J Clin Invest 91 1993 1800 1809
45. R. Vittikuti, D.A. Towler Osteogenic regulation of vascular calcification an early perspective Am J Physiol Endocrinol Metab 286 2004 E686 E696
46. R.S. Farivar, L.H. Cohn Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation J Thorac Cardiovasc Surg 126 2003 969 976
47. T.E. David, J. Ivanov Is degenerative calcification of the native aortic valve similar to calcification of bioprosthetic heart valves? J Thorac Cardiovasc Surg 126 2003 939 941
48. S.S. Srivasta, P.B. Maercklein, J. Veinot, W.D. Edwards, C.M. Johnson, L.A. Fitzpatrick Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves J Clin Invest 5 1997 996 1009
49. B. Jian, P.L. Jones, Q. Li, E.R. Mohler III, F.J. Schoen, R.J. Levy Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis Am J Pathol 159 2001 321 327
50. B. Jian, N. Narula, Q.Y. Li, E.R. Mohler III, R.J. Levy Progression of aortic valve stenosis TGF-beta 1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis Ann Thorac Surg 75 2003 457 465
51. T. Wada, M.D. McKee, S. Steitz, C.M. Giachelli Calcification of vascular smooth muscle cell cultures. Inhibition by osteopontin Circ Res 84 1999 166 178
52. F. Parhami, B. Basseri, J. Hwang, Y. Tintut, L.L. Demer High-density lipoprotein regulates calcification of vascular cells Circ Res 91 2002 570 576
53. Q.Y. Li, P.L. Jones, R.P. Lafferty, D. Safer, R.J. Levy Thymosin beta4 regulation, expression and function in aortic valve interstitial cells J Heart Valve Dis 11 2002 726 735
54. G. Luo, P. Duy, M.D. McKee Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein Nature 386 1997 78 81
55. M.Y. Speer, M.D. McKee, R.E. Guldberg Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice evidence for osteopontin as an inducible inhibitor of vascular calcification in-vivo J Exp Med 196 2002 1047 1055
56. N. Vyavahare, P.L. Jones, S. Tallapragada, R.J. Levy Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats Am J Pathol 157 2000 885 893
57. J.W. Love Autologous tissue heart valves 1993 RG Landes Austin, Texas
58. P. Human, P. Zilla Inflammatory and immune processes the neglected villain of bioprosthetic degeneration? J Long Term Eff Med Implants 11 2001 199 220
59. P. Human, P. Zilla The possible role of immune responses in bioprosthetic heart valve failure J Heart Valve Dis 10 2001 460 466
60. M.L. Salgaller, P.K. Bajpai Immunogenicity of glutaraldehyde-treated bovine pericardial tissue xenografts in rabbits J Biomed Mater Res 19 1985 1 12
61. M. Dahm, W.D. Lyman, A.B. Schwell, S.M. Factor, R.W. Frater Immunogenicity of glutaraldehyde-tanned bovine pericardium J Thorac Cardiovasc Surg 99 1990 1082 1090
62. A.P. Rocchini, K.M. Weesner, K. Heidelberger, D. Keren, D. Behrendt, A. Rosenthal Porcine xenograft valve failure in children an immunologic response Circulation 64 1981 II162 II171
63. R.J. Levy, F.J. Schoen, S.L. Howard Mechanism of calcification of porcine aortic valve cusps role of T-lymphocytes Am Cardio 52 1983 629 631
64. F.J. Schoen, R.J. Levy, S.L. Hilbert, R.W. Bianco Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety J Thorac Cardiovasc Surg 104 1992 1285 1288
65. M. Jones, E.E. Eidbo, S.L. Hilbert, V.J. Ferans, R.E. Clark Anticalcification treatments of bioprosthetic heart valves in vivo studies in sheep J Card Surg 4 1989 69 73
66. J.P. Gott, Pan-Chih, L.M. Dorsey Calcification of porcine valves a successful new method of antimineralization Ann Thorac Surg 53 1992 207 215
67. F.J. Schoen Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium J Heart Valve Dis 7 1998 174 179
68. R.J. Levy, F.J. Schoen, S.A. Lund, M.S. Smith Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy Experimental studies of optimal dosages and therapeutic durations. J Thorac Cardiovasc Surg 94 1987 551 557
69. R.J. Levy, J. Wolfrum, F.J. Schoen, M.A. Hawley, S.A. Lund, R. Langer Inhibition of calcification of bioprosthetic heart valves by local controlled release diphosphonate Science 71 1985 349 356
70. R.J. Levy, N. Vyavahare, M. Ogle, P. Ashworth, R. Bianco, F.J. Schoen Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep background, mechanisms, and synergism J Heart Valve Dis 12 2003 209 216
71. C.L. Webb, F.J. Schoen, R.J. Levy Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue stability and calcification inhibition studies Exp Mol Pathol 50 1989 291 302
72. C.L. Webb, J.J. Benedict, F.J. Schoen, J.A. Linden, R.J. Levy Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups Ann Thorac Surg 46 1988 309 316
73. T.P. Johnston, C.L. Webb, F.J. Schoen, R.J. Levy Site-specific delivery of ethanehydroxy diphosphonate from refillable polyurethane reservoirs to inhibit bioprosthetic tissue calcification J Control Release 25 1993 227 240
74. S.M. Carpentier, A.F. Carpentier, L. Chen, M. Shen, L.J. Quintero, T.H. Witzel Calcium mitigation in bioprosthetic tissues by iron pretreatment the challenge of iron leaching Ann Thorac Surg 63 1997 1514 1515
75. 3 in rat subdermal model studies Am J Pathol 138 1991 971 981
76. M. Bailey, H. Xiao, M. Ogle, N. Vyavahare Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification Am J Path 159 2001 1981 1986
77. W. Chen, J.D. Kim, F.J. Schoen, R.J. Levy Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde crosslinked porcine aortic valves J Biomed Mater Res 28 1994 1485 1495
78. W. Chen, F.J. Schoen, R.J. Levy Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic valves Circulation 90 1994 323 329
79. B. Fyfe, F.J. Schoen Pathological analysis of nonstented Freestyle aortic root bioprostheses treated with amino oleic acid Semin Thorac Cardiovasc Surg 11 1999 151 156
80. G. Fradet, N. Bleese, E. Busse The Mosaic valve clinical performance at seven years results from a multicenter prospective clinical trial J Heart Valve Dis 13 2004 239 247
81. D. Hirsch, J. Drader, T.J. Thomas, F.J. Schoen, J.T. Levy, R.J. Levy Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate preincubation and controlled release studies J Biomed Mater Res 27 1993 1477 1484
82. T. Bottio, G. Thiene, E. Pettenazzo Hancock II bioprostheses a glance at the microscope in mid-long-term explants J Thorac Cardiovasc Surg 126 2003 99 105
83. T.E. David, S. Armstrong, Z. Sun The Hancock II bioprosthesis at 12 years Ann Thorac Surg 66 1998 S95 S98
84. N.R. Vyavahare, W. Chen, R. Joshi Current progress in anticalcification for bioprosthetic and polymeric heart valves Cardiovasc Pathol 6 1997 219 229
85. N. Vyavahare, D. Hirsch, E. Lerner Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanism Circulation 95 1997 479 488
86. N.R. Vyavahare, D. Hirsch, E. Lerner Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation mechanistic studies of protein structure and water-biomaterial relationships J Biomed Mater Res 40 1998 577 585
87. G.J. Wilson, D.W. Courtman, P. Klement, J.M. Lee, H. Yeger Acellular matrix a biomaterials approach for coronary artery and heart valve replacement Ann Thorac Surg 60 1995 S353 S358
88. D.W. Courtman, C.A. Pereira, V. Kashef, D. McComb, J.M. Lee, G.J. Wilson Development of a pericardial acellular matrix biomaterial biochemical and mechanical effects of cell extraction J Biomed Mater Res 28 1994 655 666
89. P. Simon, M.T. Kasimir, G. Seebacher Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients Eur J Cardiothorac Surg 23 2003 1002 1006
90. J.F. Bechtel, M. Muller-Steinhardt, C. Schmidtke, A. Bruswik, U. Stierle, H.H. Sievers Evaluation of the decellularized pulmonary valve homograft (SynerGraft) J Heart Valve Dis 12 2003 734 739
91. L.J. Southern, H. Hughes, P.V. Lawford, M.R. Clench, N.J. Manning Glutaraldehyde-induced cross-links a study of model compounds and commercial bioprosthetic valves J Heart Valve Dis 9 2000 241 248
92. M. Hendriks, F. Eveaerts, M. Verhoeven Alternative fixation of bioprostheses J Long-Term Effects Med Implants 11 2001 163 183
93. P. Zilla, C. Weissenstein, M. Bracher High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue J Heart Valve Dis 6 1997 490 491
94. P. Zilla, C. Weissenstein, P. Human, T. Dower, U.O. von Oppell High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model Ann Thorac Surg 70 2000 2091 2095
95. M. Grabenwoger, M. Grimm, E. Ebyl Decreased tissue reaction to bioprosthetic heart valve material after L-glutamic acid treatment. A morphological study J Biomed Mater Res 26 1992 1231 1240
96. A.E. Trantina-Yates, P. Human, P. Zilla Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model J Heart Valve Dis 12 2003 93 100
97. P. Human, D. Bezuidenhout, M. Torrianni, M. Hendriks, P. Zilla Optimization of diamine bridges in glutaraldehyde treated bioprosthetic aortic wall tissue Biomaterials 23 2002 2099 2103
98. D.J. Myers, G. Nakaya, G.M. Girardot, G.W. Christie A comparison between glutaraldehyde and diepoxide-fixed stentless porcine aortic valves biochemical and mechanical characterization and resistance to mineralization J Heart Valve Dis 4 1995 S98 S101
99. T. Xi, J. Ma, W. Tian, X. Lei, S. Long, B. Xi Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds a study of calcification tests in-vitro and in-vivo J Biomed Mater Res 26 1992 1241 1251
100. P.B. Van Wachem, L.A. Brouwer, R. Zeeman In vivo behavior of epoxy-crosslinked porcine heart valve cusps and walls J Biomed Mater Res 53 2000 18 27
101. P.B. Van Wachem, L.A. Brouwer, R. Zeeman Tissue reactions to epoxy-crosslinked porcine heart valves post-treated with detergents or a dicarboxylic acid J Biomed Mater Res 55 2001 415 423
102. M.A. Moore, R.E. Phillips Biocompatibility and immunologic properties of pericardial tissue stabilized by dye-mediated photooxidation J Heart Valve Dis 6 1997 307 315
103. F.J. Schoen Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium J Heart Valve Dis 7 1998 174 179
104. K.M. Kim Cells, rather than extracellular matrix, nucleate apatite in glutaraldehyde-treated vascular tissue J Biomed Mater Res 59 2002 639 645
105. M.F. Ogle, S.J. Kelly, R.W. Bianco, R.J. Levy Calcification resistance with aluminum-ethanol treated porcine aortic valve bioprostheses in juvenile sheep Ann Thorac Surg 75 2003 1267 1273
106. R.J. Levy, N. Vyavahare, M. Ogle, P. Ashworth, R. Bianco, F.J. Schoen Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep background, mechanisms, and synergism J Heart Valve Dis 12 2003 209 216
107. A.E. Trantina-Yates, P. Human, P. Zilla Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model J Heart Valve Dis 12 2003 93 100
108. F. Evaerts, M. Torrianni, M.J. van Luyn, P.B. Van Wachem, J. Feijen, M. Hendriks Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method Biomaterials 25 2004 5523 5530
109. W. Flameng, S. Ozaki, B. Meuris Antimineralization treatments in stentless porcine bioprostheses An experimental study. J Heart Valve Dis 10 2001 489 494
110. B. Meuris, R. Phillips, M.A. Moore, W. Flameng Porcine stentless bioprostheses prevention of aortic wall calcification by dye-mediated photooxidation Artif Organs 27 2003 537 543
111. Zilla P, Bezuidenhout D, Human P. Carbodiimide treatment dramatically potentiates the anticalcific effect of alpha-amino oleic acid on glutaraldehyde-fixed aortic wall tissue. Ann Thorac Surg 2005;79:905-10.